Life Science News

RSS

Researchers identify previously unknown cause of fatal newborn brain disorder

Researchers at King Abdullah University of Science and Technology (KAUST) and King Faisal Specialist Hospital and Research Center (KFSHRC) identify a previously unknown cause of a fatal newborn brain disorder, giving long-awaited answers to families whose children were affected by the disease.

11 Nov 2026

T-Cypher Bio extends footprint in purpose-built laboratory space at Abingdon Science Park, Oxford

T-Cypher Bio ("T-Cypher), a biotechnology company developing novel T cell receptor (TCR)-based T cell engagers that target high copy number antigens, today announced its relocation to Abingdon Science Park, Oxford, UK.

11 Nov 2026

Mogrify to present preclinical proof-of-concept data for first-in-class retinal in vivo reprogramming therapy

Mogrify Limited (Mogrify®), a regenerative medicine company developing a novel class of in vivo reprogramming therapies, today announced it will present preclinical proof-of-concept data at FLORetina-ICOOR 2026.

From Mogrify 11 Nov 2026

L.B. Bohle will be showcasing productive, energy-efficient and scalable OSD solutions at PMEC India 2026

The challenge for India’s pharmaceutical manufacturers is clear: How to reliably scale production, reduce energy costs, and safeguard operators – all at once. From November 24 to 26, 2026, L.B. Bohle will present these solutions at stand 9C02 in the India Expo Centre & Mart (IEML) in Greater Noida.

From L.B. Bohle Maschinen und Verfahren GmbH 11 Nov 2026

Study proposes overlooked genetic mechanism behind schizophrenia and bipolar disorder

Schizophrenia and bipolar disorder run in families with a stubbornness that twin studies put at 81 percent heritability.

10 Nov 2026

Qureight’s fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, and Contineum Therapeutics, Inc. (Contineum), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that Qureight’s Fibr8™ quantitative imaging biomarker is being used as a secondary endpoint in Contineum’s PROPEL-IPF Phase 2 clinical trial examining the safety and efficacy of PIPE-791, Contineum’s lead drug candidate, in idiopathic pulmonary fibrosis (IPF) patients.

10 Nov 2026

The Critical Role of Sample Storage in Drug Discovery and Development

Astoriom's CEO, Will Edwards, highlights the importance of biological sample management and storage stability in advancing drug discovery and development.

10 Nov 2026

Phage protein study opens new path for future antibiotics

Drug-resistant bacteria are becoming more common worldwide, posing a major public health challenge. Addressing this problem requires finding new ways to eliminate bacteria, which in turn requires analyzing essential cellular processes that could serve as targets for future antibiotics.

9 Nov 2026

Histone subvariant H3mm15 plays key role in sperm development

Researchers from Kyushu University have found that H3mm15, a histone H3.3 subvariant, contributes to normal sperm development in mice by helping regulate gene expression during spermatogenesis.

8 Nov 2026

AI tool uncovers hidden interactions among human mitochondrial proteins

Artificial intelligence is helping Texas A&M AgriLife Research scientists fast-track answers to a long-standing question in human biology: What do hundreds of mystery proteins in the mitochondria actually do?

6 Nov 2026

Study maps key regions driving inflammation in aging hearts

Scientists have long known that aging drives inflammation in the heart, but exactly how those changes are distributed throughout the organ has remained unclear.

6 Nov 2026

Light-powered reaction gives discarded drug compounds new potential

Throughout the drug development process, which can take a decade or more, tens of thousands of chemical compounds are produced that never go on to become medicines.

6 Nov 2026

Advanced tumor profiling uncovers hidden hereditary cancer-predisposition syndrome

Using next-generation sequencing (NGS) to profile tumor cells from patients with solid tumors, researchers at Fondazione Policlinico Universitario A. Gemelli IRCCS identified genetic alterations associated with cancer predisposition in 10% of the subjects examined.

6 Nov 2026

Study uncovers new shortcut mechanism behind cancer cell division

Living cells are one of the few materials that can replicate themselves, and this is crucial for tissue development and recovering from injury or illness.

6 Nov 2026

Philanthropists donate $6 million to establish the UVA Biotech Innovation Fund

The University of Virginia Paul and Diane Manning Institute of Biotechnology received gifts totaling $6 million from philanthropists to establish the UVA Biotech Innovation Fund.

6 Nov 2026

New European real-world evidence supporting Pepaxti in heavily pretreated multiple myeloma to be presented at ASH 2026

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces that two abstracts highlighting real-world clinical outcomes for Pepaxti (melflufen) in relapsed, refractory multiple myeloma (RRMM) have been accepted for presentation at the 68th American Society of Hematology (ASH) Annual Meeting, taking place in New Orleans, USA, December 12–15, 2026.

6 Nov 2026

MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines

MRM Health, a clinical-stage biotech developing microbiome-based therapies for immune-mediated diseases, and Biocodex, an independent French pharmaceutical company with more than 70 years of experience in the microbiome field, today announced the launch of a strategic partnership to establish specialized manufacturing capabilities for live biotherapeutic products.

6 Nov 2026

Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 Meeting

Evaxion A/S (“Evaxion”), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, will present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia (AML), in a poster session at the American Society of Hematology (ASH) Annual Meeting and Exposition in New Orleans, Louisiana, December 12-15, 2026.

5 Nov 2026

Novel method identifies active tRNAs during cellular protein synthesis

In a new study in Nature Methods, researchers at the Centre for Genomic Regulation (CRG) in Barcelona describe a technique that looks only at the tRNAs on ribosomes busy making proteins.

5 Nov 2026

New genomic tools improve detection of rare DNA changes

WashU Medicine researchers have verified the accuracy of genetics tools to correctly identify all the rare DNA changes that make up an individual's genomic mosaic, paving the way to understanding these variants' impact on health and disease.

5 Nov 2026

1
2
3
4
...
1152
Next

Life Science News

Researchers identify previously unknown cause of fatal newborn brain disorder

T-Cypher Bio extends footprint in purpose-built laboratory space at Abingdon Science Park, Oxford

Mogrify to present preclinical proof-of-concept data for first-in-class retinal in vivo reprogramming therapy

L.B. Bohle will be showcasing productive, energy-efficient and scalable OSD solutions at PMEC India 2026

Study proposes overlooked genetic mechanism behind schizophrenia and bipolar disorder

Qureight’s fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

The Critical Role of Sample Storage in Drug Discovery and Development

Phage protein study opens new path for future antibiotics

Histone subvariant H3mm15 plays key role in sperm development

AI tool uncovers hidden interactions among human mitochondrial proteins

Study maps key regions driving inflammation in aging hearts

Light-powered reaction gives discarded drug compounds new potential

Advanced tumor profiling uncovers hidden hereditary cancer-predisposition syndrome

Study uncovers new shortcut mechanism behind cancer cell division

Philanthropists donate $6 million to establish the UVA Biotech Innovation Fund

New European real-world evidence supporting Pepaxti in heavily pretreated multiple myeloma to be presented at ASH 2026

MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines

Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 Meeting

Novel method identifies active tRNAs during cellular protein synthesis

New genomic tools improve detection of rare DNA changes

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (3rd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation